Urate oxidase should remain mandatory in patients at high risk of tumor lysis syndrome
- PMID: 24360225
- DOI: 10.1053/j.ajkd.2013.06.029
Urate oxidase should remain mandatory in patients at high risk of tumor lysis syndrome
Comment on
-
Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis.Am J Kidney Dis. 2013 Sep;62(3):481-92. doi: 10.1053/j.ajkd.2013.02.378. Epub 2013 May 14. Am J Kidney Dis. 2013. PMID: 23684124
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources